approved

State of Oregon Invests in Meriwether Group Capitals Hero Fund Following Third-Party Review

With three years of audited returns of 11%, the private credit platform gains institutional backing to support next-stage growthPORTLAND, Ore.--(BUSINESS…

3 days ago

EURneffy (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)

EURneffy (neffy® in the U.S.) offers a new delivery method for adrenaline in the U.K. for adults and children (>30…

1 week ago

Cango Inc. Announces Results of Second Extraordinary General Meeting

HONG KONG, July 17, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company") today announced that all resolutions…

1 week ago

Johnson & Johnson Launches VARIPULSE Platform across Asia-Pacific, Advancing Atrial Fibrillation Treatment

The VARIPULSE™ Platform is the first Pulsed Field Ablation (PFA) system fully integrated with the CARTO™ 3 electroanatomical mapping system,…

2 weeks ago

Sirtex Medical’s SIR-Spheres Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable Hepatocellular Carcinoma

Expanded indication makes SIR-Spheres® the first and only radioembolization therapy in the U.S. approved to treat both unresectable hepatocellular carcinoma…

3 weeks ago

VivoPower Commences $29 Million Shareholder Loan Financing Retirement Plan

LONDON, July 07, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (Nasdaq: VVPR) (“VivoPower” or the “Company”) announced today that its…

3 weeks ago

Investigational combination of first-in-class bispecific antibodies TALVEY (talquetamab) and TECVAYLI (teclistamab) shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease

Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response rate through dual targeting of…

1 month ago

Sarepta Provides Safety Update for ELEVIDYS and Initiates Steps to Strengthen Safety in Non-Ambulatory Individuals with Duchenne

- The Company is developing an enhanced immunosuppressive regimen in consultation with a panel of multi-disciplinary clinical experts and engaging…

1 month ago

Avricore Grants Options

June 14, 2025 01:05 ET  | Source: Avricore Health Inc. VANCOUVER, British Columbia, June 14, 2025 (GLOBE NEWSWIRE) -- AVRICORE…

1 month ago

JZXN Raises Funds through Convertible Notes to Acquire Bitcoin, Initiating a Strategic Layout of Thousands of Bitcoins

HANGZHOU, China, June 11, 2025 /PRNewswire/ -- JZXN Holdings, Inc. (NASDAQ: JZXN; the "Company") announced that its board of directors has…

1 month ago